IRIS
SAMPAOLESI, MAURILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.734
AS - Asia 5.659
EU - Europa 4.315
SA - Sud America 804
Continente sconosciuto - Info sul continente non disponibili 255
AF - Africa 186
OC - Oceania 15
Totale 18.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.561
CN - Cina 2.831
SG - Singapore 1.230
IE - Irlanda 1.009
UA - Ucraina 618
BR - Brasile 606
HK - Hong Kong 588
FI - Finlandia 494
VN - Vietnam 478
DE - Germania 472
RU - Federazione Russa 411
IT - Italia 309
FR - Francia 279
GB - Regno Unito 244
SE - Svezia 209
IN - India 132
BE - Belgio 95
ZA - Sudafrica 91
CA - Canada 79
BD - Bangladesh 72
AR - Argentina 61
MX - Messico 48
IQ - Iraq 45
TR - Turchia 44
EC - Ecuador 41
NL - Olanda 36
PL - Polonia 31
ID - Indonesia 29
JP - Giappone 24
VE - Venezuela 24
PK - Pakistan 23
ES - Italia 22
UZ - Uzbekistan 21
CO - Colombia 19
SA - Arabia Saudita 18
KE - Kenya 16
TN - Tunisia 16
MA - Marocco 15
EG - Egitto 14
PY - Paraguay 14
AU - Australia 13
CL - Cile 13
CZ - Repubblica Ceca 12
JO - Giordania 12
MY - Malesia 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
JM - Giamaica 11
PE - Perù 11
CR - Costa Rica 10
DZ - Algeria 9
IR - Iran 9
LT - Lituania 9
AT - Austria 8
AZ - Azerbaigian 8
EU - Europa 8
CH - Svizzera 7
KZ - Kazakistan 7
UY - Uruguay 7
PT - Portogallo 6
TH - Thailandia 6
BO - Bolivia 5
EE - Estonia 5
GT - Guatemala 5
KG - Kirghizistan 5
KR - Corea 5
RO - Romania 5
SN - Senegal 5
ET - Etiopia 4
GR - Grecia 4
LV - Lettonia 4
MU - Mauritius 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
LK - Sri Lanka 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
Totale 18.696
Salva come PNG Salva come JPEG
Città #
Dublin 1.009
Chandler 938
Jacksonville 786
San Jose 769
Ashburn 692
Nanjing 642
Singapore 626
Hong Kong 577
Dallas 416
Beijing 373
Boardman 340
Nanchang 270
Council Bluffs 258
Princeton 216
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 180
Los Angeles 178
Lauterbourg 176
Ho Chi Minh City 174
Changsha 163
Ann Arbor 157
Jiaxing 157
Helsinki 141
Hangzhou 110
Tianjin 106
Hanoi 102
Buffalo 92
Milan 89
Johannesburg 80
Munich 67
Shanghai 66
Moscow 63
Woodbridge 62
Redondo Beach 60
New York 59
Santa Clara 59
Pavia 54
Verona 51
Orem 45
São Paulo 45
Brussels 41
Herent 33
Norwalk 31
Chennai 29
Seattle 29
Toronto 29
Turku 29
Brooklyn 26
Fairfield 26
Guangzhou 26
Warsaw 26
Frankfurt am Main 25
Chicago 24
Baghdad 23
Kunming 23
Montreal 23
Pune 23
The Dalles 23
Da Nang 22
Houston 22
Washington 22
Des Moines 20
Falkenstein 20
Leuven 20
Tokyo 20
San Francisco 19
Tashkent 18
Amsterdam 16
Brasília 16
Denver 16
Phoenix 16
Auburn Hills 15
Jinan 15
Mumbai 15
Nuremberg 15
Rio de Janeiro 15
Ankara 14
Falls Church 14
London 14
Manchester 14
Nairobi 14
Poplar 14
Quito 14
Biên Hòa 13
Boston 13
Haiphong 13
Lahore 13
Mexico City 13
Stockholm 13
Zhengzhou 13
Belo Horizonte 12
Guayaquil 12
Amman 11
Atlanta 11
Ningbo 11
Redwood City 11
Caracas 10
Totale 12.332
Salva come PNG Salva come JPEG
Nome #
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 192
Electromagnetic fields influence the gene expression of SAOS-2 cell line 177
Evaluation of energy expenditure in athletes practising horseback riding 172
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 170
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 166
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 164
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 162
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 156
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 156
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 154
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 152
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 148
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 145
Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model 144
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 133
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 132
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 131
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 128
Adult Stem Cells and Skeletal Muscle Regeneration 128
Gene signature of muscle hypertrophy 128
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 126
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 124
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 123
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 123
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 123
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 121
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 120
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 120
Cell therapy strategies and improvements for muscular dystrophy. 118
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 117
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 115
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 115
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 115
Bedside to bench: a look at experimental research with a clinical trial checklist 113
In vitro and in vivo tissue engineering approaches in regenerative medicine 113
Aging affects the in vivo regenerative potential of human mesoangioblasts 113
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 113
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 112
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 112
Evaluation of the effects of a dynamic culture on osteogenic differentiation of oral-periosteal cells grown on PLGA sponges 112
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 110
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 110
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 110
The effects of micro-grafts in the treatment of androgenetic alopecia 110
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 109
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 109
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 108
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 108
Brief Communication Arising 107
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 107
About Mesoangioblasts 104
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 103
Alteration of cardiac progenitor cell potency in GRMD dogs 103
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 103
Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells 103
Magic-F1 transgene cooperates with Pax 3 during early myogenesis to induce muscular hypertrophy 103
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 103
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 102
Cardiac development and remodelling in Magic-F1 transgenic mice 102
Guide cells support muscle regeneration and affect neuro-muscular junction organization 102
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation 102
Inducing muscular hypertrophy by recombinant proteins 101
Poly-l-Lactic Acid Nanofiber–Polyamidoamine Hydrogel Composites: Preparation, Properties, and Preliminary Evaluation as Scaffolds for Human Pluripotent Stem Cell Culturing 101
Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery 100
In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly-L-lysine-treated titanium-6-aluminium-4-vanadium 99
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 97
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 97
Magic F-1: a new engineered protein involved in muscular hypertrophy and regeneration 97
The investigation of the effects of autologous micrografts in the process of wound healing 97
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives 97
Skeletal muscle engineering: scaffolds and recombinant proteins 97
Hamster cardiomyocytes: a model of myocardial regeneration? 96
Muscle hypertrophy and vascularization induction using recombinant proteins 96
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 95
Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. 95
Skeletal muscle regenerative approach combining stem cells and 3D bioprinting 95
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 94
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 93
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 93
New therapies for muscular dystrophy: cautious optimism. 93
Terapia cellulare mesenchimale nella distrofia muscolare 93
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 92
Exploring wound-healing genomic machinery with a network-based approach 92
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 90
Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo 90
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 90
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 89
Stem Cell homing and regulation: new insights from muscular dystrophy 89
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 89
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 89
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 89
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells 89
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 88
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 88
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 88
Welcome to Cardiovascular Research in 2015 88
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 88
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 87
Mononucleated Cells to Regenerate Skeletal Muscle Syncytial Tissues 87
Stem cell-niche and lysosomal cathepsins 86
Totale 11.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.567
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022835 0 0 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/20252.473 38 242 116 78 40 87 125 170 559 71 287 660
2025/20266.123 473 485 757 748 695 223 1.124 248 459 491 291 129
2026/2027452 81 311 60 0 0 0 0 0 0 0 0 0
Totale 18.968